PRVA vs. HIMS, GH, OPCH, RDNT, SHC, BTSG, SGRY, WGS, CON, and LFST
Should you be buying Privia Health Group stock or one of its competitors? The main competitors of Privia Health Group include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), Sotera Health (SHC), BrightSpring Health Services (BTSG), Surgery Partners (SGRY), GeneDx (WGS), Concentra Group Holdings Parent (CON), and LifeStance Health Group (LFST). These companies are all part of the "healthcare" industry.
Privia Health Group vs.
Hims & Hers Health (NYSE:HIMS) and Privia Health Group (NASDAQ:PRVA) are both mid-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, community ranking, institutional ownership and dividends.
Hims & Hers Health has a beta of 1.37, suggesting that its stock price is 37% more volatile than the S&P 500. Comparatively, Privia Health Group has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500.
63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 94.5% of Privia Health Group shares are owned by institutional investors. 17.7% of Hims & Hers Health shares are owned by insiders. Comparatively, 14.2% of Privia Health Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Hims & Hers Health currently has a consensus target price of $37.31, indicating a potential upside of 16.75%. Privia Health Group has a consensus target price of $26.67, indicating a potential upside of 16.35%. Given Hims & Hers Health's higher possible upside, equities research analysts clearly believe Hims & Hers Health is more favorable than Privia Health Group.
Hims & Hers Health has a net margin of 8.19% compared to Privia Health Group's net margin of 0.75%. Hims & Hers Health's return on equity of 10.97% beat Privia Health Group's return on equity.
Privia Health Group received 29 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 75.79% of users gave Privia Health Group an outperform vote while only 37.07% of users gave Hims & Hers Health an outperform vote.
Privia Health Group has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.
In the previous week, Hims & Hers Health had 12 more articles in the media than Privia Health Group. MarketBeat recorded 25 mentions for Hims & Hers Health and 13 mentions for Privia Health Group. Hims & Hers Health's average media sentiment score of 1.08 beat Privia Health Group's score of 1.00 indicating that Hims & Hers Health is being referred to more favorably in the media.
Summary
Hims & Hers Health beats Privia Health Group on 10 of the 19 factors compared between the two stocks.
Get Privia Health Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for PRVA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Privia Health Group Competitors List
Related Companies and Tools
This page (NASDAQ:PRVA) was last updated on 3/28/2025 by MarketBeat.com Staff
